BackChemours Company Overview
Chemours Company

Chemours Company Target Price

Analysts' average 12-month price target for Chemours Company is $24.

Get informed when a big investor buys or sells

+ Follow

Share Price

$15.77

Average Target Price

$23.7550.6% upside

12 analysts in the last 4 months

High: $30 | Low: $17

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-13BMO Capital$1814.1% upsideOpen
2026-08-13Goldman SachsDuffy Fischer$177.8% upsideOpen
2026-08-10Morgan StanleyVincent Andrews$1814.1% upsideOpen
2026-08-10UBSJoshua Spector$1814.1% upsideOpen
2026-08-06RBC Capital$2239.5% upsideOpen
2026-08-05Mizuho Securities$2239.5% upsideOpen
2026-05-13Alembic Global$3090.2% upsideOpen
2026-05-11Morgan StanleyVincent Andrews$2133.2% upsideOpen
2026-05-11RBC Capital$2983.9% upsideOpen
2026-05-08UBS$3090.2% upsideOpen
2026-05-06Mizuho SecuritiesJohn Roberts$3090.2% upsideOpen
2026-04-28Truist FinancialPeter Osterland$3090.2% upsideOpen
2026-04-10RBC CapitalArun Viswanathan$2664.9% upsideOpen
2026-04-09UBS$2983.9% upsideOpen
2026-04-09Truist Financial$2771.2% upsideOpen
2026-02-23JefferiesLaurence Alexander$177.8% upsideOpen
2026-02-23UBS$2345.8% upsideOpen
2026-02-23BMO Capital$1920.5% upsideOpen
2026-02-23Mizuho Securities$177.8% upsideOpen
2026-02-23Morgan StanleyVincent Andrews$177.8% upsideOpen
2026-01-21Truist Financial$2133.2% upsideOpen
2026-01-19BMO CapitalJohn McNulty$2026.8% upsideOpen
2026-01-16RBC Capital$1814.1% upsideOpen
2025-11-10Truist FinancialPeter Osterland$1814.1% upsideOpen
2025-10-16Mizuho SecuritiesJohn Roberts$1814.1% upsideOpen
2025-10-14RBC Capital$1920.5% upsideOpen
2025-10-06UBSJoshua Spector$2133.2% upsideOpen
2025-09-23Mizuho SecuritiesJohn Roberts$1920.5% upsideOpen
2025-05-07UBSJoshua Spector$177.8% upsideOpen
2025-04-15Mizuho SecuritiesJohn Roberts$154.9% downsideOpen
2024-10-11RBC CapitalArun Viswanathan$2877.6% upsideOpen
2024-10-07BMO CapitalJohn McNulty$32102.9% upsideOpen
2024-08-06BMO CapitalJohn McNulty$3090.2% upsideOpen
2024-06-07Mizuho SecuritiesJohn Roberts$2558.5% upsideOpen
2024-05-29UBSRich Hilliker$3196.6% upsideOpen
2024-04-09BMO CapitalJohn McNulty$34115.6% upsideOpen
2024-04-01UBSJoshua Spector$2877.6% upsideOpen
2024-04-01CFRAEmily Nassedd Mitsch$1814.1% upsideOpen
2024-03-13D.A. DavidsonLinda Bolton Weiser$2452.2% upsideOpen
2023-12-01RBC CapitalArun Viswanathan$40153.6% upsideOpen
2023-10-30Morgan StanleyVincent Andrews$33109.3% upsideOpen
2023-01-10RBC CapitalArun Viswanathan$33109.3% upsideOpen
2022-05-04RBC Capital$48204.4% upsideOpen
2021-05-20Bank of America SecuritiesMatthew DeYoe$42166.3% upsideOpen
2021-05-10Morgan StanleyVincent Andrews$35121.9% upsideOpen
2021-05-06Argus ResearchDavid Coleman$40153.6% upsideOpen

Chemours Company (CC) FAQ

Chemours Company posts a target price of $24. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $24 for CC means covering analysts, on average, see the stock 50.6% upside of $15.77 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for CC's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Chemours Company's other metric pages and overview cover the third.

Judging Chemours Company against Consumer Discretionary peers is usually better than using a market-wide rule of thumb. Business models inside Consumer Discretionary are more comparable, which makes gaps in target price easier to interpret. Start with $24 here, then scan peer and history charts to see if the gap is persistent.